SPEICH LIMITED

Company number 15112409 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

SPEICH LIMITED - Analysis Report

Company Number: 15112409

Analysis Date: 2025-07-29 20:41 UTC

Financial Health Assessment for SPEICH LIMITED (Period ending 31 December 2024)


1. Financial Health Score: C

Explanation:
SPEICH LIMITED’s financial health is currently moderate with some concerning symptoms. The company holds significant investment property assets (£281,942) which bolster its net asset position (£32,104). However, the presence of net current liabilities (-£16,158) and substantial long-term creditors (£233,680) indicate financial strain. This score reflects a business in its infancy, with early-stage balance sheet imbalances that require close monitoring and management action.


2. Key Vital Signs: Critical Metrics and Interpretation

Metric Value (£) Interpretation
Current Assets 7,587 Low level of liquid assets; limited short-term liquidity.
Cash at Bank 7,301 Nearly all current assets are cash, indicating limited receivables or stock.
Debtors 286 Minimal trade receivables, low working capital inflow from sales.
Current Liabilities 23,745 Over 3 times current assets; potential liquidity risk in short term.
Net Current Assets (Working Capital) -16,158 Negative working capital signals a liquidity mismatch – company owes more soon than it holds in liquid assets.
Creditors after 1 year 233,680 Large long-term debt or obligations, possibly linked to investment property financing.
Total Assets less Current Liabilities 265,784 Strong asset base after deducting short-term liabilities.
Net Assets (Equity) 32,104 Positive but modest equity cushion; shareholder funds are limited compared to total liabilities.
Investment Property Value 281,942 Significant fixed asset; no independent valuation, so market volatility or impairment risk may exist.
Share Capital 100 Very low paid-up capital, reflecting early-stage company status.
Profit and Loss Reserve 32,004 Accumulated retained earnings or losses; positive but small.

3. Diagnosis: What the Financial Data Reveals About Business Health

  • Liquidity Symptoms: The company shows symptoms of “short-term distress” with negative net current assets (-£16,158). This indicates it may struggle to cover immediate obligations with available liquid assets, a warning sign akin to a patient with low blood pressure signaling poor circulation.

  • Asset Strength but Financing Risk: The company’s main asset is investment property valued at £281,942, but this is financed heavily by long-term creditors (£233,680). This resembles a patient with a strong muscle (asset base) but burdened with a heavy load (debt), creating strain on the system.

  • Early Stage and Limited Operating History: Incorporated in September 2023, the company has a short operating period. The financial statements cover the first 16 months, so the business is in its infancy. Limited turnover or profit information is available, and operating performance cannot be fully assessed.

  • Balance Sheet Composition: The company has a low share capital (£100) and modest equity (£32,104), signaling limited financial buffer. The reliance on borrowed funds could be risky if cash flow does not improve.

  • No Audit & Limited Disclosures: The accounts are unaudited and abridged, which is typical for small companies but reduces transparency about detailed profitability and cash flow.


4. Recommendations: Specific Actions to Improve Financial Wellness

  1. Improve Working Capital Management:

    • Seek to increase current assets through faster collection of receivables or building cash reserves.
    • Negotiate better payment terms with creditors to ease short-term cash flow pressure.
    • Consider short-term financing solutions to cover working capital gaps.
  2. Monitor Debt Levels Closely:

    • Review long-term creditor arrangements to ensure debt servicing is sustainable.
    • Explore refinancing options if interest rates or repayment terms are unfavorable.
    • Ensure clear plans for generating income from investment property to cover debt costs.
  3. Enhance Revenue Generation:

    • As the company is involved in “Activities of head offices” (SIC 70100), focus on building operating revenues to support cash flow.
    • Develop a robust business plan targeting growth and profitability.
  4. Valuation and Asset Review:

    • Obtain an independent valuation of investment property to confirm fair value and detect any impairment risks.
    • Regularly review fixed assets for potential write-downs or revaluation.
  5. Strengthen Equity Base:

    • Consider capital injections from shareholders to build a stronger equity buffer.
    • Retain earnings within the company to improve reserves over time.
  6. Transparency and Governance:

    • Ensure timely filing and consider audited accounts as the company grows to improve stakeholder confidence.
    • Maintain clear financial records and controls as the business expands.

Medical Analogy Summary:

SPEICH LIMITED currently exhibits signs of a “young patient” with a strong skeletal frame (investment property) but weak blood flow (liquidity). The heart of the business—cash flow—is not yet robust, posing risks of short-term financial distress. Without intervention to strengthen liquidity and manage debt, the patient risks developing financial fatigue.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.